These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6353400

  • 21. [Alpha fetoproteins and fibrinogen degradation products (FDP) in amniotic fluid].
    Diani F, Conte N, Carozzi S.
    Boll Soc Ital Biol Sper; 1978 May 15; 54(9):824-6. PubMed ID: 81066
    [No Abstract] [Full Text] [Related]

  • 22. Alpha-fetoprotein values in late second trimester pregnancy.
    Webb T, Edwards JH, Crawley JM, Thompson RA, Harnden DG, Rushton DI.
    Lancet; 1978 Sep 09; 2(8089):578. PubMed ID: 79946
    [No Abstract] [Full Text] [Related]

  • 23. Antenatal detection of severe central nervous system defects.
    Nelson MM, Coetzee EJ.
    S Afr Med J; 1977 Oct 29; 52(19):745. PubMed ID: 74858
    [No Abstract] [Full Text] [Related]

  • 24. Early prenatal diagnosis of neural-tube defects by ultrasound-guided fetoscopy.
    Rodeck CH, Campbell S.
    Lancet; 1978 May 27; 1(8074):1128-9. PubMed ID: 77419
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Origin of maternal serum AFP.
    Lancet; 1979 Nov 10; 2(8150):999-1000. PubMed ID: 91780
    [No Abstract] [Full Text] [Related]

  • 27. Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
    Buamah PK, Taylor P, Ward AM.
    Clin Chem; 1981 Oct 10; 27(10):1658-60. PubMed ID: 6169467
    [Abstract] [Full Text] [Related]

  • 28. The improvement of the antenatal detection of fetal neural tube defects using discriminant analysis.
    Pettit BR, King GS.
    Clin Biochem; 1984 Feb 10; 17(1):46-51. PubMed ID: 6200255
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Protein markers in disease (1). Alphafetoprotein and the prenatal diagnosis of neural tube defects.
    Brock DJ.
    J R Coll Surg Edinb; 1978 May 10; 23(3):184-92. PubMed ID: 78981
    [No Abstract] [Full Text] [Related]

  • 31. [Alpha-fetoproteins in obstetrics].
    Weitzel H.
    Gynakologe; 1983 Sep 10; 16(3):148-54. PubMed ID: 6196260
    [No Abstract] [Full Text] [Related]

  • 32. [Contribution of amniocentesis to prenatal screening of neural tube closing defects: evaluation of 10 years of a center's experience].
    Guibaud S, Capella-Bonnet M, Simplot A.
    J Genet Hum; 1985 Sep 10; 33(3-4):339-45. PubMed ID: 2414399
    [Abstract] [Full Text] [Related]

  • 33. Interpreting amniotic-fluid alpha-fetoprotein.
    Lancet; 1978 Jan 14; 1(8055):100. PubMed ID: 74544
    [No Abstract] [Full Text] [Related]

  • 34. Insulin and human growth hormone in the amniotic fluid in normal pregnancy and in cases of fetal central nervous system anomalies.
    Wiśniewski L, Jezuita J, Bogoniowska Z, Grześ A.
    Z Geburtshilfe Perinatol; 1983 Jan 14; 187(3):151-2. PubMed ID: 6351453
    [Abstract] [Full Text] [Related]

  • 35. Amniotic fluid gel cholinesterase density ratios in fetal open defects of the neural tube and ventral wall.
    Goldfine C, Miller WA, Haddow JE.
    Br J Obstet Gynaecol; 1983 Mar 14; 90(3):238-40. PubMed ID: 6338901
    [Abstract] [Full Text] [Related]

  • 36. [Prenatal diagnosis of chromosome abnormalities and genetic metabolic disorders (proceedings)].
    Knörr K.
    Arch Gynakol; 1977 Jul 29; 224(1-4):159-66. PubMed ID: 74992
    [No Abstract] [Full Text] [Related]

  • 37. Amniotic-fluid A.F.P. in late second trimester pregnancy.
    Ward AM, Bates G, Crookes CA.
    Lancet; 1978 Nov 18; 2(8099):1093-4. PubMed ID: 82105
    [No Abstract] [Full Text] [Related]

  • 38. Avoidance of anencephalic and spina bifida births by maternal serum-alphafetoprotein screening.
    Ferguson-Smith MA, Rawlinson HA, May HM, Tait HA, Vince JD, Gibson AA, Robinson HP, Ratcliffe JG.
    Lancet; 1978 Jun 24; 1(8078):1330-3. PubMed ID: 78097
    [Abstract] [Full Text] [Related]

  • 39. Letter: F.D.P. in amniotic fluid as marker for neural-tube defects.
    Weiss RR, Macri JN, Merskey C.
    Lancet; 1976 Feb 07; 1(7954):304. PubMed ID: 55614
    [No Abstract] [Full Text] [Related]

  • 40. Some problems of alpha-fetoprotein screening.
    Bennett MJ, Blau K, Johnson RD, Chamberlain GV.
    Lancet; 1978 Dec 16; 2(8103):1296-7. PubMed ID: 82794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.